Epinephrine Injector
DLA Troop Support · DLA TROOP SUPPORT
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation SPE2D2-26-R-0009 in this department, oldest first.
- Apr 29, 2026Pre-solicitationOpen
- Oct 1, 2026 · this noticeSolicitation
- Oct 14, 2026SolicitationOpen
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
The Defense Logistics Agency is issuing a solicitation for a national requirements contract for Epinephrine Injectors. Procurement details follow. Epinephrine 0.3 MG/0.3 ML Injection, Auto-Injector 2S in 2 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Depar… (show all)
tment of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov. Interested parties should contact Jeremy Brown at (445) 737-5419, (jeremy.brown@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current solicitation date is October of 2026.
Who won similar work
16 award notices on SAM.gov in the last 24 months. Matched by: Same office (DLA TROOP SUPPORT), same product/service code (PSC) 6505 and NAICS 325412.
Single-winner award sizes (14): middle half $3.4M to $14.2M, median $8.3M; range $1.8M to $133.2M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| Golden State Medical Supply, Inc. | 8 | $184.6M | Oct 14, 2026 |
| AVKARE LLC | 2 | $13.7M | Sep 1, 2026 |
| Exelan Pharmaceuticals Inc. | 1 | $24.1M | Jun 13, 2025 |
| Bayer HealthCare Pharmaceuticals Inc | 1 | $10.3M | Jun 3, 2026 |
| PURACAP LABORATORIES LLC | 1 | $6.4M | Jun 9, 2026 |
| SpecGx, LLC | 1 | $5.9M | Sep 9, 2026 |
| PADAGIS SOURCING SOLUTIONS LLC | 1 | $3.2M | Jul 23, 2026 |
| RADHA PHARMACEUTICALS INC | 1 | – | Sep 14, 2026 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either (2 here). Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
- Oct 14, 2026Golden State Medical Supply, Inc.$15.3MPravastatin SolicitationNo listed company matched (Materiality N/A)
- Oct 7, 2026GOLDEN STATE MEDICAL SUPPLY INC$4.3MQuetiapine Fumarate XR TabletsNo listed company matched (Materiality N/A)
- Sep 24, 2026GOLDEN STATE MEDICAL SUPPLY INC$17.6M (modification)Olopatadine HCL 0.1% Ophthalmic SolutionContract modification, not a new award (Materiality N/A)
- Sep 14, 2026RADHA PHARMACEUTICALS INC$23.3M (modification)Bupropion HCL ERContract modification, not a new award (Materiality N/A)
- Sep 9, 2026SpecGx, LLC$5.9MMethylphenidate HCL IRNo listed company matched (Materiality N/A)
- Sep 3, 2026GOLDEN STATE MEDICAL SUPPLY, INC.$2.4MSolifenacin AwardNo listed company matched (Materiality N/A)
- Sep 1, 2026AVKARE LLC$11.9MAnastrozole - AwardNo listed company matched (Materiality N/A)
- Jul 23, 2026PADAGIS SOURCING SOLUTIONS LLC$3.2MClindamycin Phosphate - Benzoyl Peroxide GelNo listed company matched (Materiality N/A)
- Jul 21, 2026GOLDEN STATE MEDICAL SUPPLY INC$12.1MTolterodine Tartrate ER 24HR CapsulesNo listed company matched (Materiality N/A)
- Jul 14, 2026GOLDEN STATE MEDICAL SUPPLY, INC.$133.2MDuloxetine HCL DR CapsulesNo listed company matched (Materiality N/A)
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Defense Logistics Agency since 2024 (0 filings)
- 0 of their lobbyists list a past Defense Logistics Agency job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 32 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.